Showing results (921-930 of 1,191) with videos related to

Sort By:
Pageof 120
Cancer|August 11, 2016
Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaNicholas J Short, Hagop M Kantarjian, Koji Sasaki, et al.
Blood Advances|April 24, 2020
Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemiaNicholas J Short, Keyur P Patel, Maher Albitar, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2024
Artificial Intelligence Assessment of Chest Radiographs for COVID-19Koji Sasaki, Guillermo Garcia-Manero, Masayuki Nigo, et al.
Blood Advances|March 24, 2019
NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapyGuillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Koji Sasaki, et al.
BMC Cancer|August 20, 2016
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort studyDavid P Steensma, Medrdad Abedi, Rafael Bejar, et al.
American Journal of Hematology|December 23, 2016
Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitorNicholas J Short, Hagop M Kantarjian, Koji Sasaki, et al.
Cancer|June 17, 2021
Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysisKoji Sasaki, Hagop M Kantarjian, Kiyomi Morita, et al.
The Lancet. Oncology|October 4, 2015
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 studyElias Jabbour, Hagop Kantarjian, Farhad Ravandi, et al.
Hematological Oncology|August 29, 2018
Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndromeChristopher B Benton, Kelly S Chien, Ayalew Tefferi, et al.
Haematologica|March 23, 2023
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)Guillaume Richard-Carpentier, Caitlin R Rausch, Koji Sasaki, et al.
Pageof 120